Callan Family Office’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$487K Buy
2,568
+20
+0.8% +$2.97K 0.01% 828
2026
Q1
$237K Buy
2,548
+26
+1% +$2.3K 0.01% 1002
2025
Q4
$203K Buy
+2,522
New +$211K ﹤0.01% 1054

Other funds holding ACLS

Callan Family Office's ACLS Position: Q2 2026 in Review

Callan Family Office increased its Axcelis (ACLS) stake by 0.78% in Q2 2026, buying an estimated $2.97K and bringing the position to 2,568 shares worth $487K. The position accounts for 0.01% of the portfolio, ranked #828.

Callan Family Office first reported a position in ACLS in Q4 2025 and has held it in 3 quarters since. 443 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

  • Callan Family Office held 2,568 shares of Axcelis worth $487K as of Q2 2026.
  • Callan Family Office bought 20 Axcelis shares in Q2 2026, an estimated $2.97K.
  • Axcelis made up 0.01% of Callan Family Office's portfolio in Q2 2026, its #828 holding.
  • Callan Family Office first reported a position in Axcelis in Q4 2025 and has held it in 3 quarters since.
  • 443 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.